ContextVision AB (publ) (OSL:CONTX)
Norway · Delayed Price · Currency is NOK 4.190
-0.110 (-2.56%)
Dec 23, 2025, 4:25 PM CET
ContextVision AB Market Cap
ContextVision AB has a market cap or net worth of 316.22 million as of December 24, 2025. Its market cap has decreased by -20.79% in one year.
Market Cap
316.22M
Enterprise Value
253.57M
Revenue
115.15M
Ranking
n/a
PE Ratio
83.81
Stock Price
4.19
Market Cap Chart
Since March 18, 1997, ContextVision AB's market cap has increased from 296.00M to 316.22M, an increase of 6.83%. That is a compound annual growth rate of 0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 316.22M | -25.69% |
| Dec 30, 2024 | 425.52M | -28.57% |
| Dec 29, 2023 | 595.73M | -15.75% |
| Dec 30, 2022 | 707.14M | -44.49% |
| Dec 30, 2021 | 1.27B | -25.49% |
| Dec 30, 2020 | 1.71B | 114.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.81B |
| Nordhealth AS | 2.94B |
| Photocure ASA | 1.84B |
| Thor Medical ASA | 1.71B |
| ArcticZymes Technologies ASA | 1.12B |
| Omda AS | 980.27M |
| Vistin Pharma ASA | 904.63M |
| Gentian Diagnostics ASA | 863.65M |